Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are anticipating strong growth driven by the robust https://mollyprvk943002.win-blog.com/18270351/analyzing-eli-lilly-s-q3-results